Sign in

CIK 0001818331 · Large accelerated filer

GeneDx Holdings Corp.

Sign in to watch
Ticker
WGS
Exchange
Nasdaq
Industry
Services-Health Services
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851966622
Phone
888-729-1206
Business address
333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
Former names
Sema4 Holdings Corp., CM Life Sciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,839,245
in 5 filings

Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stueland Katherine −$1.3M CHIEF EXECUTIVE OFFICER sold 11% of stake
  2. Feeley Kevin −$503K CHIEF FINANCIAL OFFICER sold 11% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-17 Fuchs Thomas Director Option exercise +1,146 1,146
2026-09-17 Fuchs Thomas Director Option exercise · Restricted Stock Unit −1,146 2,292
2026-09-16 Feeley Kevin CHIEF FINANCIAL OFFICER Option exercise +7,197 48,673
2026-09-16 Feeley Kevin CHIEF FINANCIAL OFFICER Sale −586 $94.26 $55K 48,087
2026-09-16 Feeley Kevin CHIEF FINANCIAL OFFICER Sale −52 $95.41 $5K 48,035
2026-09-16 Feeley Kevin CHIEF FINANCIAL OFFICER Sale −541 $96.90 $52K 47,494
2026-09-16 Feeley Kevin CHIEF FINANCIAL OFFICER Sale −1,470 $98.27 $144K 46,024
2026-09-16 Feeley Kevin CHIEF FINANCIAL OFFICER Sale −1,079 $99.00 $107K 44,945
2026-09-16 Feeley Kevin CHIEF FINANCIAL OFFICER Option exercise · Restricted Stock Unit −7,197 14,393
2026-09-16 Stueland Katherine CHIEF EXECUTIVE OFFICER Option exercise +18,750 125,977
2026-09-16 Stueland Katherine CHIEF EXECUTIVE OFFICER Sale −1,648 $94.26 $155K 124,329
2026-09-16 Stueland Katherine CHIEF EXECUTIVE OFFICER Sale −148 $95.41 $14K 124,181
2026-09-16 Stueland Katherine CHIEF EXECUTIVE OFFICER Sale −1,525 $96.90 $148K 122,656
2026-09-16 Stueland Katherine CHIEF EXECUTIVE OFFICER Sale −4,141 $98.27 $407K 118,515
2026-09-16 Stueland Katherine CHIEF EXECUTIVE OFFICER Sale −3,039 $99.00 $301K 115,476
2026-09-16 Stueland Katherine CHIEF EXECUTIVE OFFICER Option exercise · Restricted Stock Unit −18,750 37,500
2026-09-09 Feeley Kevin CHIEF FINANCIAL OFFICER Option exercise +2,462 42,761
2026-09-09 Feeley Kevin CHIEF FINANCIAL OFFICER Sale −1,285 $84.22 $108K 41,476
2026-09-09 Feeley Kevin CHIEF FINANCIAL OFFICER Option exercise · Restricted Stock Unit −2,462 2,463
2026-09-09 Stueland Katherine CHIEF EXECUTIVE OFFICER Option exercise +6,547 110,919

Page 1 of 23 · 450 trades